📊 Biopharmaceutical Industry Reacts to EU Reform Proposals Reforms to the EU’s pharmaceutical legislation are shaking things up! According to a GlobalData survey, opinions on the impact of these proposals are mixed. Some see positives, others are negatives, and many remain neutral. The mid-year update of “The State of the Biopharmaceutical Industry 2024” highlights the deep ambivalence among sector leaders. This reflects the varied impacts on innovative, generic, and branded generic companies. The uncertainty about final reforms is palpable. 📉 📰 Read more: https://lnkd.in/gUUkKpYa #Pharma #EUReforms #Biopharmaceuticals #GlobalData #IndustryInsights #Innovation #Healthcare #Regulations #PharmaIndustry #DataAndAnalytics #KnowMore
GlobalData Healthcare
Information Services
Predict the future to transform your business in the healthcare, medical devices & pharma industries.
About us
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value. Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services. Among other benefits, our informed industry perspectives help clients understand how to generate the maximum return from their key markets, identify opportunities from emerging trends, and devise strategies for growth with confidence.
- Website
-
https://www.globaldata.com/
External link for GlobalData Healthcare
- Industry
- Information Services
- Company size
- 1,001-5,000 employees
- Headquarters
- London
- Type
- Public Company
- Founded
- 2010
- Specialties
- Research and Consulting, Strategic Analysis, Competitive Benchmarking, Market Forecasting, Medical, Pharmaceutical, and Data Analysis
Locations
-
Primary
John Carpenter Street
London, GB
Employees at GlobalData Healthcare
Updates
-
Stay informed, stay ahead 🚀 Get your essential #healthcare round-up covering #health technology, #hospital development projects, #cardiovascular, #oncology, and #respiratory therapy, and more. Subscribe to #DECODED now 👉https://lnkd.in/eNqZDECh
-
-
🦴 Osteoporosis: A Growing Concern In 2023, there were over 20 million diagnosed cases of osteoporosis in the 7MM. 📈 This number is set to increase with an annual growth rate of over 1% from 2023 to 2033. Osteoporosis weakens the skeleton by reducing bone density and quality over time, leading to fragile bones and a higher risk of fractures. Understanding the process of bone remodeling is crucial in addressing this condition. https://lnkd.in/gMv_VnTY #OsteoporosisAwareness #BoneHealth #HealthcareTrends #MedicalResearch #HealthyLiving
Osteoporosis Epidemiology Analysis and Forecast to 2033
globaldata.com
-
Infertility in major markets is projected to grow 🌍! In 2023, the market size was a significant $1.6 billion. By 2033, expect a CAGR of over 3% 📈, driven by increasing rates of ART treatments 🏥. https://lnkd.in/gWqw_z6N #FemaleInfertility #Healthcare #Innovation #MedicalAdvancements
Female Infertility in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033
globaldata.com
-
🌟 The biosimilar market is set for significant growth! According to GlobalData, the rise of biologics is transforming treatments for tough-to-treat diseases, paving the way for biosimilars to flourish. As patents expire, these cost-effective alternatives will expand, offering broader access to essential therapies. Adeleke Badejo, PhD MS, Managing Analyst of Immunology at GlobalData, highlights the contrast in drug costs between countries with public healthcare, like Canada, France, Germany, and Japan, and the US. 🌏 Regulatory laws and negotiated prices in these countries keep biological therapy costs lower compared to the US. https://lnkd.in/g4TUDA86 #Biosimilars #Healthcare #Biologics #Pharmaceuticals #GlobalData #MedicalInnovation #HealthEconomics #ExploreMore
Biosimilar market poised for significant growth in the coming years, says GlobalData
globaldata.com
-
🚀 The transcatheter accessories market is on the rise! Valued at $12.01 billion in 2023, it’s set to grow at a CAGR of 5%+ over the next decade. 🌟 These crucial accessories help safely navigate the cardiovascular system for procedures like angioplasty, atherectomy, and valve replacement. https://lnkd.in/gxgh-inE #HealthcareInnovation #MedicalTech #TranscatheterMarket #GrowthForecast #CardiovascularHealth
Transcatheter Accessories Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
globaldata.com
-
🌟 New Insights on ADHD! Our latest report dives deep into the ADHD market, valued at $11.9 billion in 2022 across the US, France, Germany, Italy, Spain, the UK, and Japan 📊. Despite a projected decline, ADHD remains a clinically heterogeneous disorder with significant unmet needs 🌍. Explore the comprehensive assessment of ADHD epidemiology, clinical trials, and future forecasts until 2032 📅. https://lnkd.in/gfgwp9Wq #ADHD #Healthcare #MarketReport #NeurodevelopmentalDisorders #GlobalHealth
Attention Deficit Hyperactivity Disorder (ADHD) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
globaldata.com
-
🌟 Embracing the future of healthcare with AI-powered diagnostics! The shift towards precision medicine is here, and it's transforming patient safety. AI diagnostic tools analyze biological and clinical data to create personalized healthcare plans. Elia Garcia from GlobalData highlights the integration of AI into electronic medical records. This innovation offers clinicians easy access to diagnostic insights and patient data. 📊 The FDA's approval of Prenosis’ Sepsis ImmunoScore is a game-changer for patient safety in hospitals. This AI tool enhances clinical workflow efficiency and collaborative decision-making. https://lnkd.in/g5WSsry3 #AIinHealthcare #PrecisionMedicine #PatientSafety #DigitalHealth
AI-powered diagnostics in digital healthcare transforming patient safety, says GlobalData
globaldata.com
-
📊 Looking for extensive coverage of the radiosurgery systems market? Our latest market report has got you covered! 🌟 Dive into major pipeline products, complete with descriptions, licensing, collaborations, and developmental activities. 📝 Discover the impact of COVID-19 and stay ahead with key clinical trial data on ongoing trials. 🧬 Don't miss out on insights from top players and their projects! 🔗 Ready to explore the future of radiosurgery systems? Check out the report now! https://lnkd.in/gsDCgM_Y #Radiosurgery #HealthcareInnovation #MedicalTechnology #ClinicalTrials #COVID19Impact #MarketInsights #FutureOfHealthcare
Radiosurgery Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
globaldata.com
-
1 curated daily email 📬 8 #healthcare news stories 💡 100s of business opportunities 🌍 Subscribe now to get your #DECODED newsletter 👉 https://lnkd.in/eD2Qq9m4
-